OSLO--(BUSINESS WIRE)--Regulatory News: Abstracts of two articles to be published in the highly ranked Journal of Alzheimer’s Disease have been posted today on the journal’s web site. This will build confidence in ADtect® among clinicians and pharmaceutical companies and confirm DiaGenic’s leading position as a provider of biomarkers in the CNS field.
